The role of chronic norovirus infection in the enteropathy associated with common variable immunodeficiency

American Journal of Gastroenterology

Volumn 110, Issue 2, 2015, Pages 320-327

  Woodward, Jeremy M ^a   Gkrania Klotsas, Effrossyni ^a   Cordero Ng, Anthony Y K ^a   Aravinthan, Aloysious ^a   Bandoh, Betty N ^a   Liu, Hongxiang ^a   Davies, Susan ^a   Zhang, Hongyi ^a   Stevenson, Philip ^a   Curran, Martin D ^a   Kumararatne, Dinakantha ^a  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AZATHIOPRINE; BUDESONIDE; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; PREDNISOLONE; RIBAVIRIN; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; VIRUS RNA;

ADD ON THERAPY; ADULT; AGED; ARTICLE; CHRONICITY; CLINICAL ARTICLE; COMMON VARIABLE IMMUNODEFICIENCY; DRUG WITHDRAWAL; DUODENUM BIOPSY; ENTEROPATHY; FECES; FECES ANALYSIS; FEMALE; GLUTEN FREE DIET; HLA TYPING; HUMAN; INTESTINE BIOPSY; INTESTINE VILLUS ATROPHY; INTRAVENOUS FEEDING; MALE; MIDDLE AGED; NONHUMAN; NOROVIRUS; NOROVIRUS INFECTION; PARENTERAL NUTRITION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; VIRAL CLEARANCE; VIRUS LOAD; VIRUS STRAIN;

EID: 84964211432     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2014.432     Document Type: Article

References (34)

1. Krones E, Högenauer C. Diarrhea in the immunocompromised patient. Gastroenterol Clin North Am 2012; 41: 677-701.
2. Henke-Gendo C, Harste G, Juergens-Saathoff B et al. New real-time PCR detects prolonged Norovirus excretion in highly immunosuppressed patients and children. J Clin Microbiol 2009; 47: 2855-62.
3. Bok K, Green KY. Norovirus gastroenteritis in immunocompromised patients. N Engl J Med 2012; 367: 2126-32.
4. Capizzi T, Makari-Judson G, Steingart R et al. Chronic diarrhea associated with persistent Norovirus excretion in patients with chronic lymphocytic leukemia: report of two cases. BMC Infect Dis 2011; 11: 131.
5. Ludwig A, Adams O, Laws HJ et al. Quantitative detection of Norovirus excretion in pediatric patients with cancer and prolonged gastroenteritis and shedding of Norovirus. J Med Virol 2008; 80: 1461-7.
6. Florescu DF, Hermsen ED, Kwon JY et al. Is there a role for oral human immunoglobulin in the treatment for Norovirus enteritis in immunocompromised patients? Pediatr Transplant 2011; 15: 718-21.
7. Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodefi ciencies. Representing PAGID (Pan-American Group for Immunodefi ciency) and ESID (European Society for Immunodefi ciencies). Clin Immunol 1999; 93: 190-7.
8. Daniels JA, Lederman HM, Maitra A et al. Gastrointestinal tract pathology in patients with common variable immunodefi ciency (CVID): a clinicopathologic study and review. Am J Surg Pathol 2007; 31: 1800-12.
9. Khodadad A, Aghamohammadi A, Parvaneh N et al. Gastrointestinal manifestations in patients with common variable immunodefi ciency. Dig Dis Sci 2007; 52: 2977-83.
10. Teahon K, Webster AD, Price AB et al. Studies on the enteropathy associated with primary hypogammaglobulinaemia. Gut 1994; 35: 1244-9.
11. Malamut G, Verkarre V, Suarez F et al. The enteropathy associated with common variable immunodefi ciency: the delineated frontiers with celiac disease. Am J Gastroenterol 2010; 105: 2262-75.
12. Chapel H, Lucas M, Lee M et al. Common variable immunodefi ciency disorders: division into distinct clinical phenotypes. Blood 2008; 112: 277-86.
13. Meini A, Pillan NM, Villanacci V et al. Prevalence and diagnosis of celiac disease in IgA-defi cient children. Ann Allergy Asthma Immunol 1996; 77: 333-6.
14. Stene LC, Honeyman MC, Hoff enberg EJ et al. Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am J Gastroenterol 2006; 101: 2333-40.
15. Aghamohammadi A, Mohammadi J, Parvaneh N et al. Progression of selective IgA defi ciency to common variable immunodefi ciency. Int Arch Allergy Immunol 2008; 147: 87-92.
16. Castigli E, Geha RS. TACI, isotype switching, CVID and IgAD. Immunol Res 2007; 38: 102-11.
17. Haimila K, Einarsdottir E, de Kauwe A et al. The shared CTLA4-ICOS risk locus in celiac disease, IgA defi ciency and common variable immunodefi-ciency. Genes Immun 2009; 10: 151-61.
18. Mannon PJ, Fuss IJ, Dill S et al. Excess IL-12 but not IL-23 accompanies the infl ammatory bowel disease associated with common variable immunodefi ciency. Gastroenterology 2006; 131: 748-56.
19. Chua I, Standish R, Lear S et al. Anti-tumour necrosis factor-alpha therapy for severe enteropathy in patients with common variable immunodefi ciency (CVID). Clin Exp Immunol 2007; 150: 306-11.
20. Troeger H, Loddenkemper C, Schneider T et al. Structural and functional changes of the duodenum in human Norovirus infection. Gut 2009; 58: 1070-7.
21. Rolfe KJ, Parmar S, Mururi D et al. An internally controlled, one-step, realtime RT-PCR assay for Norovirus detection and genogrouping. J Clin Virol 2007; 39: 318-21.
22. Kageyama T, Kojima S, Shinohara M et al. Broadly reactive and highly sensitive assay for Norwalk-like viruses based on real-time quantitative reverse transcription-PCR. J Clin Microbiol 2003; 41: 1548-57.
23. Chang KO, George DW. Interferons and ribavirin eff ectively inhibit Norwalk virus replication in replicon-bearing cells. J Clin Virol 2007; 81: 12111-8.
24. Rocha-Pereira J, Jochmans D, Dallmeier K et al. Inhibition of Norovirus replication by the nucleoside analogue 2'-C-methylcytidine. Biochem Biophys Res Commun 2012; 427: 796-800.
25. Alam I, Lee JH, Cho KJ et al. Crystal structures of murine Norovirus-1 RNA-dependent RNA polymerase in complex with 2-thiouridine or ribavirin Virology 2012; 426: 143-51.
26. Atmar RL, Opekun AR, Gilger MA et al. Norwalk virus shedding aft er experimental human infection. Emerg Infect Dis 2008; 14: 1553-7.
27. Gallimore CI, Cubitt D, du Plessis N et al. Asymptomatic and symptomatic excretion of Noroviruses during a hospital outbreak of gastroenteritis. J Clin Microbiol 2004; 42: 2271-4.
28. Marshall JA, Hellard ME, Sinclair MI et al. Failure to detect Norovirus in a large group of asymptomatic individuals. Public Health 2004; 118: 230-3.
29. MacLennan C, Dunn G, Huissoon AP et al. Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodefi cient man. Lancet 2004; 363: 1509-13.
30. Saif MA, Bonney DK, Bigger B et al. Chronic Norovirus infection in pediatric hematopoietic stem cell transplant recipients: a cause of prolonged intestinal failure requiring intensive nutritional support. Pediatric Transplant 2011; 15: 505-9.
31. Zullo A, Romiti A, Rinaldi V et al. Gastric pathology in patients with common variable immunodefi ciency. Gut 1999; 45: 77-81.
32. Siebenga J, Kroneman A, Vennema H et al. Food-borne viruses in Europe network report: the Norovirus GII. 4 2006b (for US named Minerva-like, for Japan Kobe034-like, for UK V6) variant now dominant in early seasonal surveillance. Euro surveillance: bulletin europeen sur les maladies transmissibles Euro Surveill. 2008; 13: pii=8009.
33. Kundu S, Lockwood J, Depledge DP et al. Next generation whole genome sequencing identifi es the direction of Norovirus transmission in linked patients. Clin Infect Dis 2013; 57: 407-14.
34. van de Ven AA, Douma JW, Rademaker C et al. Pleconaril-resistant chronic parechovirus-associated enteropathy in agammaglobulinaemia. Antivir Ther 2011; 16: 611-4.